Journal rankings · indicator year 2024
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2024
Endocrinology, Diabetes and Metabolism journal rankings 2024
157 ranked journals · Subfield in Medicine
Endocrinology, Diabetes and Metabolism has 157 ranked journals in 2024. The median journal has an OJR of 0.92, below the world average of 1.00, unchanged on 2023; Q1 starts at OJR 1.27. The top three are Endocrine Reviews, The Lancet Diabetes & Endocrinology, and Diabetes Care.
Ranks and citation indicators: 2024. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2021–2023, the window the 2024 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery980
- Pulmonary and Respiratory Medicine364
- Public Health, Environmental and Occupational Health316
- Cardiology and Cardiovascular Medicine289
- Infectious Diseases263
- Oncology243
- Epidemiology187
- Neurology175
- Radiology, Nuclear Medicine and Imaging161
- Physiology159
- Endocrinology, Diabetes and Metabolism157
- Psychiatry and Mental health144
Show all 42 subfields
- Orthopedics and Sports Medicine125
- Ophthalmology100
- Pediatrics, Perinatology and Child Health100
- Dermatology92
- Obstetrics and Gynecology85
- Hematology83
- Rheumatology67
- Nephrology65
- Complementary and alternative medicine59
- Reproductive Medicine52
- Pharmacology49
- Emergency Medicine42
- Geriatrics and Gerontology37
- Rehabilitation34
- Otorhinolaryngology33
- Hepatology30
- Pathology and Forensic Medicine29
- Immunology and Allergy26
- Critical Care and Intensive Care Medicine23
- Genetics19
- Anesthesiology and Pain Medicine14
- Urology12
- Health Informatics9
- Gastroenterology7
- Internal Medicine6
- Family Practice2
- Transplantation2
- Anatomy0
- Biochemistry0
- Microbiology0
157 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2023. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2021–2023, the window the 2024 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2021–2023 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2015 to 2024. | Compare |
|---|---|---|---|---|---|---|---|
1Endocrine ReviewsOxford University Press · United States | 10.56Q1 | 26.42 0.93 up from 2023 | 110 | 85% | $3,750 | ||
2The Lancet Diabetes & EndocrinologyElsevier BV · Netherlands | 7.50Q1 | 18.22 1.68 down from 2023 | 442 | 36% | $7,280 | ||
3Diabetes CareAmerican Diabetes Association · United States | 4.94Q1 | 13.99 1.05 up from 2023 | 1,330 | 84% | — | ||
4Endocrine PathologySpringer Science+Business Media · United States | 4.14Q1 | 14.80 1.50 up from 2023 | 127 | 51% | $3,190 | ||
5Cardiovascular DiabetologyOABioMed Central · United Kingdom | 3.46Q1 | 11.57 2.07 up from 2023 | 859 | 100% | $4,290 | ||
6DiabetologiaSpringer Science+Business Media · Germany | 3.30Q1 | 10.19 1.19 up from 2023 | 641 | 98% | $3,490 | ||
7Journal of Internal MedicineWiley · United Kingdom | 2.79Q1 | 8.19 0.62 up from 2023 | 482 | 74% | $4,780 | ||
8Best Practice & Research Clinical Endocrinology & MetabolismElsevier BV · United Kingdom | 2.73Q1 | 6.92 0.07 down from 2023 | 188 | 46% | $4,450 | ||
9Reviews in Endocrine and Metabolic DisordersSpringer Science+Business Media · Netherlands | 2.72Q1 | 9.61 0.51 up from 2023 | 228 | 54% | $5,590 | ||
10Diabetes & Metabolism JournalOAKorean Diabetes Association · South Korea | 2.61Q1 | 6.93 0.20 down from 2023 | 262 | 100% | $500 | ||
11Current Diabetes ReportsSpringer Science+Business Media · United States | 2.57Q1 | 7.65 0.75 up from 2023 | 154 | 50% | $4,890 | ||
12Endocrinology and Metabolism Clinics of North AmericaElsevier BV · United States | 2.43Q1 | 4.71 1.09 down from 2023 | 171 | 15% | $3,540 | ||
13Diabetes/Metabolism Research and ReviewsWiley · United Kingdom | 2.17Q1 | 6.63 1.57 up from 2023 | 287 | 67% | $4,780 | ||
14Diabetes Research and Clinical PracticeElsevier BV · Netherlands | 2.08Q1 | 3.63 3.72 down from 2023 | 1,205 | 23% | $4,410 | ||
15European Journal of EndocrinologyOxford University Press · United Kingdom | 1.95Q1 | 5.62 0.28 down from 2023 | 529 | 59% | $4,292 | ||
16World Journal of DiabetesOAHong Kong SAR China | 1.95Q1 | 5.45 0.14 up from 2023 | 377 | 100% | — | ||
17ThyroidMary Ann Liebert, Inc. · United States | 1.92Q1 | 5.97 0.10 down from 2023 | 465 | 37% | — | ||
18Diabetes Technology & TherapeuticsMary Ann Liebert, Inc. · United States | 1.90Q1 | 6.15 0.10 up from 2023 | 395 | 52% | — | ||
19Pediatric DiabetesWiley · Denmark | 1.88Q1 | 6.37 1.36 up from 2023 | 300 | 97% | $2,740 | ||
20The Journal of Clinical Endocrinology & MetabolismOxford University Press · United States | 1.86Q1 | 5.16 0.08 up from 2023 | 2,186 | 70% | $3,750 | ||
21Diabetes Obesity and MetabolismWiley · United Kingdom | 1.81Q1 | 5.47 0.03 up from 2023 | 1,038 | 75% | $5,380 | ||
22Therapeutic Advances in Endocrinology and MetabolismOASAGE Publishing · United Kingdom | 1.77Q1 | 4.99 0.26 up from 2023 | 143 | 100% | $2,650 | ||
23Frontiers in EndocrinologyOAFrontiers Media · Switzerland | 1.77Q1 | 5.28 0.58 up from 2023 | 8,267 | 100% | $3,801 | ||
24European Thyroid JournalOAKarger Publishers · Switzerland | 1.76Q1 | 4.78 0.16 up from 2023 | 169 | 100% | — | ||
25BMJ Open Diabetes Research & CareOABMJ · United Kingdom | 1.65Q1 | 4.78 0.25 up from 2023 | 467 | 100% | $3,000 | ||
26Endocrine Related CancerBioscientifica · United Kingdom | 1.63Q1 | 4.85 0.05 down from 2023 | 248 | 42% | — | ||
27Diabetes & MetabolismElsevier BV · Netherlands | 1.62Q1 | 4.78 0.70 up from 2023 | 178 | 38% | $4,490 | ||
28Lipids in Health and DiseaseOABioMed Central · United Kingdom | 1.51Q1 | 4.51 0.03 up from 2023 | 534 | 100% | $2,990 | ||
29La Presse MédicaleElsevier BV · France | 1.48Q1 | 3.40 0.51 down from 2023 | 115 | 75% | $2,320 | ||
30Diabetology & Metabolic SyndromeOABioMed Central · United Kingdom | 1.46Q1 | 4.60 0.34 up from 2023 | 594 | 100% | $2,890 | ||
31JMIR DiabetesOACanada | 1.44Q1 | 3.64 0.35 up from 2023 | 127 | 100% | $1,873 | ||
32Journal of Diabetes ResearchOAHindawi Publishing Corporation · United Kingdom | 1.42Q1 | 3.94 0.45 down from 2023 | 435 | 100% | $2,760 | ||
33Endocrine PracticeElsevier BV · United States | 1.41Q1 | 4.76 0.66 up from 2023 | 484 | 30% | $3,480 | ||
34Clinical Diabetes and EndocrinologyOABioMed Central · United Kingdom | 1.39Q1 | 2.67 2.33 down from 2023 | 41 | 100% | $2,290 | ||
35Clinical Medicine Insights Endocrinology and DiabetesOASAGE Publishing · United States | 1.38Q1 | 3.58 0.17 down from 2023 | 70 | 100% | $2,650 | ||
36Endocrinology and MetabolismOAAcademya Publishing Co. · South Korea | 1.37Q1 | 4.21 0.03 up from 2023 | 321 | 100% | — | ||
37Journal of EndocrinologyBioscientifica · United Kingdom | 1.34Q1 | 3.69 0.08 down from 2023 | 217 | 57% | — | ||
38Journal of Endocrinological InvestigationSpringer Science+Business Media · Italy | 1.33Q1 | 3.73 0.60 down from 2023 | 754 | 55% | $4,790 | ||
39BMC Endocrine DisordersOABioMed Central · United Kingdom | 1.31Q1 | 4.06 0.35 up from 2023 | 852 | 100% | $3,190 | ||
40MaturitasElsevier BV · Netherlands | 1.27Q1 | 3.92 0.06 up from 2023 | 389 | 53% | $4,390 | ||
41EndocrinologyOxford University Press · United States | 1.26Q2 | 3.33 0.52 down from 2023 | 655 | 79% | $3,750 | ||
42Diabetes & Metabolic Syndrome Clinical Research & ReviewsElsevier BV · Netherlands | 1.25Q2 | 4.70 0.91 down from 2023 | 676 | 36% | $4,450 | ||
43Diabetes and Vascular Disease ResearchOASAGE Publishing · United Kingdom | 1.23Q2 | 3.20 0.05 up from 2023 | 104 | 100% | $2,100 | ||
44Clinical DiabetesAmerican Diabetes Association · United States | 1.20Q2 | 2.76 0.33 down from 2023 | 243 | 100% | — | ||
45Nutrition Metabolism and Cardiovascular DiseasesElsevier BV · Italy | 1.20Q2 | 3.55 0.22 down from 2023 | 951 | 41% | $3,000 | ||
46Expert Review of Clinical PharmacologyTaylor & Francis · United Kingdom | 1.20Q2 | 3.50 0.52 down from 2023 | 348 | 42% | — | ||
47Journal of Clinical & Translational EndocrinologyOAElsevier BV · Netherlands | 1.19Q2 | 2.42 1.50 down from 2023 | 79 | 100% | $3,500 | ||
48Journal of the Endocrine SocietyOAEndocrine Society · United States | 1.18Q2 | 3.15 0.23 up from 2023 | 546 | 100% | $3,255 | ||
49touchREVIEWS in EndocrinologyOATouch Medical Media · United Kingdom | 1.17Q2 | 4.07 1.39 up from 2023 | 88 | 100% | — | ||
50Hormone Research in PaediatricsKarger Publishers · Switzerland | 1.16Q2 | 2.86 0.29 down from 2023 | 221 | 59% | — |
Subfields of Medicine, with Endocrinology, Diabetes and Metabolism highlighted.
- Surgery980
- Pulmonary and Respiratory Medicine364
- Public Health, Environmental and Occupational Health316
- Cardiology and Cardiovascular Medicine289
- Infectious Diseases263
- Oncology243
- Epidemiology187
- Neurology175
- Radiology, Nuclear Medicine and Imaging161
- Physiology159
- Endocrinology, Diabetes and Metabolism157
- Psychiatry and Mental health144
- Orthopedics and Sports Medicine125
- Ophthalmology100
- Pediatrics, Perinatology and Child Health100
- Dermatology92
- Obstetrics and Gynecology85
- Hematology83
- Rheumatology67
- Nephrology65
- Complementary and alternative medicine59
- Reproductive Medicine52
- Pharmacology49
- Emergency Medicine42
- Geriatrics and Gerontology37
- Rehabilitation34
- Otorhinolaryngology33
- Hepatology30
- Pathology and Forensic Medicine29
- Immunology and Allergy26
- Critical Care and Intensive Care Medicine23
- Genetics19
- Anesthesiology and Pain Medicine14
- Urology12
- Health Informatics9
- Gastroenterology7
- Internal Medicine6
- Family Practice2
- Transplantation2
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2024. Corpus-wide, 87.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
43 additional Endocrinology, Diabetes and Metabolism journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2021–2023, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2024. Publication window: 2021–2023. How these summaries are calculated
- Ranked journals
- 157
- Window papers (baseline)
- 83,560 +10.1% from indicator year 2021
- Median OJR
- 0.9165 +3.0% from indicator year 2021
- Rising journals (2025)
- 11
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2021–2023 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 48 | 51 | 57 | 60 | 65 | 70 | 78 | 84 | 89 | 95 | 101 | 111 | 124 | 132 | 136 | 141 | 151 | 156 | 162 | 168 | 161 | 163 | 159 | 159 | 157 | 152 | |
| Window papers (baseline) | 21,857 | 24,171 | 25,806 | 27,521 | 27,880 | 30,069 | 32,732 | 36,738 | 40,740 | 46,752 | 50,540 | 53,888 | 54,290 | 56,103 | 58,424 | 61,715 | 64,393 | 66,581 | 68,391 | 70,385 | 72,729 | 75,894 | 79,750 | 82,000 | 83,560 | 87,039 | |
| Median OJR | 0.50 | 0.65 | 0.69 | 0.77 | 0.71 | 0.81 | 0.84 | 0.94 | 0.91 | 0.93 | 1.01 | 0.959 | 0.98 | 0.868 | 0.97 | 0.957 | 0.951 | 0.893 | 0.950 | 0.86 | 0.954 | 0.8896 | 0.8903 | 0.9170 | 0.9165 | 0.870 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.